On July 15, 2026, leading researchers, clinicians, and industry innovators came together to confront a central question:
why, despite remarkable advances, does so much innovation still fail to reach the patients who need it?
Watch the full program below.
Building on the vision and legacy of Dr. Peter Sheehan, the OneGuild Forum on Diabetes Innovation & Limb Preservation brought together leading researchers, clinicians, and health system innovators to explore a central question: why, despite unprecedented advances in wound biology, biomaterials, digital health, and regenerative medicine, do outcomes for patients with diabetic limb complications not improve as fast as they should?
This inaugural edition featured a keynote address, lightning research showcases from Peter Sheehan Young Innovator Award recipients, and a panel discussion with distinguished voices from academia, clinical practice, and industry — united around the theme of closing the innovation gap in limb preservation.
The Forum is now available on-demand, extending its reach to a global audience well beyond July 15.
The forum honors Dr. Peter Sheehan, a pioneer in limb preservation and diabetes complications management, whose tireless efforts transformed care models worldwide. His legacy continues to inspire innovation, integration, and a global commitment to improving outcomes for those affected by diabetes.
Keynote — The Innovation Paradox in Limb Preservation
Despite an explosion of promising advances across wound science, biomaterials, wearable technology, and regenerative medicine, amputation rates for patients with diabetic foot complications remain stubbornly high. This opening keynote frames the central question that drives the entire Forum: what is preventing innovation from reaching the patients who need it most?
Bijan Najafi, PhD
Professor of Surgery, UCLA Research Director, Center for Advanced Surgical & Interventional Technology (CASIT)
Lightning Research Showcases
Five recipients of the Peter Sheehan Young Innovator Award presented their research in rapid, high-impact showcases — each a window into the future of diabetic limb preservation. From molecular discoveries to AI-driven patient engagement, these presentations spotlight the innovations emerging from the next generation of scientists and clinicians.
Panel — From Discovery to Patient: Closing the Innovation Gap
A translational researcher who has taken discoveries from bench to startup, a clinician who treats threatened limbs daily, and industry leaders in health economics, regulatory strategy, and market access examine the barriers that prevent promising innovations from reaching patients. From FDA approval to reimbursement hurdles to adoption gaps in clinical practice, the panel explores what it takes to move a breakthrough from the laboratory to the bedside — and what the next generation of innovators needs to know.
Panelists:
Geoffrey Gurtner, MD, FACS Chair, Department of Surgery, University of Arizona
Joseph Mills, MD, FACS Professor of Surgery, Baylor College of Medicine
Amy Law VP Health Economics, Outcomes Research & Market Access, Solventum
Ryan Egeland, MD, PhD Chief Medical Officer & SVP, MedSurg, Solventum
Forum Chair
OneGuild Pulse is our monthly letter on the science, people, and ideas shaping the future of diabetes complications and limb preservation. Join a growing community of researchers, clinicians, and industry leaders.
The Peter Sheehan Young Innovator Award recognizes outstanding early-career scientists advancing tissue regeneration and limb preservation. Applications for the 2027 edition will open soon.